Galaxy Biomedical Investment Co.,Ltd. Posted 189.6 Million Yuan Net Loss in First Half of 2021

Galaxy Biomedical Investment Co.,Ltd. (北海银河生物产业投资股份有限公司) (000806.SZ) reported a net loss of 189.6 million yuan in the first half of 2021, widening 4264.2% year-on-year.

Meanwhile, the company posted 492 million yuan in revenue, down 0.7% year-on-year.

At the end of the reporting period, it had 1.8 billion yuan in total assets and 1.9 billion yuan in total liabilities, with a liability-to-asset ratio of 107.1%.

This article was automatically produced by Caixin Automation on Sept. 1, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.